Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeNon Operating Investment IncomeOperating ExpensesOperating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Wages, Salaries and Other
Others
Ratios

Nuvation Bio (NUVB) Shares Outstanding (Weighted Average) (2023 - 2025)

Nuvation Bio (NUVB) has disclosed Shares Outstanding (Weighted Average) for 3 consecutive years, with $341541.0 as the latest value for Q4 2025.

  • On a quarterly basis, Shares Outstanding (Weighted Average) rose 27.07% to $341541.0 in Q4 2025 year-over-year; TTM through Dec 2025 was $341541.0, a 27.07% increase, with the full-year FY2025 number at $341541.0, up 27.07% from a year prior.
  • Shares Outstanding (Weighted Average) was $341541.0 for Q4 2025 at Nuvation Bio, roughly flat from $340597.0 in the prior quarter.
  • In the past five years, Shares Outstanding (Weighted Average) ranged from a high of $341541.0 in Q4 2025 to a low of $218741.0 in Q1 2023.
  • A 3-year average of $269085.3 and a median of $250332.5 in 2024 define the central range for Shares Outstanding (Weighted Average).
  • Peak YoY movement for Shares Outstanding (Weighted Average): grew 0.14% in 2024, then soared 54.58% in 2025.
  • Nuvation Bio's Shares Outstanding (Weighted Average) stood at $218880.0 in 2023, then increased by 22.79% to $268772.0 in 2024, then rose by 27.07% to $341541.0 in 2025.
  • Per Business Quant, the three most recent readings for NUVB's Shares Outstanding (Weighted Average) are $341541.0 (Q4 2025), $340597.0 (Q3 2025), and $339685.0 (Q2 2025).